Learn more

MDRNA INC

Overview
  • Total Patents
    133
About

MDRNA INC has a total of 133 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are SMITH JAMES JEFFERSON, INT STEM CELL CORP and PREC BIOSCIENCES.

Patent filings per year

Chart showing MDRNA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Quay Steven C 99
#2 Ahmadian Mohammad 88
#3 Vaish Narendra K 88
#4 Mcswiggen James 87
#5 Houston Michael E 11
#6 Adami Roger C 10
#7 Costantino Henry R 9
#8 Kleppe Mary S 8
#9 Cui Kunyuan 7
#10 Johns Rachel E 7

Latest patents

Publication Filing date Title
US2010105134A1 Nucleic acid compounds for inhibiting gene expression and uses thereof
CA2677068A1 Nucleic acid compounds for inhibiting gene expression and uses thereof
US2010015708A1 Ribonucleic acids with non-standard bases and uses thereof
EP2296711A2 Multi-arm amines and uses thereof
CN101939027A Lipopeptides for delivery of nucleic acids
US2009042823A1 Uses of broad spectrum rnai therapeutics against influenza
CN101679978A hydroxymethyl substituted rna oligonucleotides and rna complexes
WO2008109503A1 Nucleic acid compounds for inhibiting ms4a1 gene expression and uses thereof
WO2008109548A2 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof
WO2008109494A1 Nucleic acid compounds for inhibiting stat3 gene expression and uses thereof
WO2008109544A1 Nucleic acid compounds for inhibiting muc1 gene expression and uses thereof
WO2008109490A2 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof
WO2008109555A2 Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof
WO2008109497A1 Nucleic acid compounds for inhibiting folh1 gene expression and uses thereof
WO2008109547A2 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof
WO2008109546A2 Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
WO2008109553A1 Nucleic acid compounds for inhibiting ptpn11 gene expression and uses thereof
WO2008109505A1 Nucleic acid compounds for inhibiting cd22 gene expression and uses thereof
WO2008109520A2 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof
WO2008109556A1 Nucleic acid compounds for inhibiting telomerase gene expression and uses thereof